title: Comparative in-vitro activities of GD-40 and other beta-lactamase inhibitors against TEM-1 and SHV-2 beta-lactamases.
authors.forename: G
authors.initials: G
authors.lastname: Danelon
authors.forename: O
authors.initials: O
authors.lastname: Mascaretti
authors.forename: M
authors.initials: M
authors.lastname: Radice
authors.forename: P
authors.initials: P
authors.lastname: Power
authors.forename: M L
authors.initials: ML
authors.lastname: Calcagno
authors.forename: E G
authors.initials: EG
authors.lastname: Mata
authors.forename: G
authors.initials: G
authors.lastname: Gutkind
mesh_terms: D019818:Clavulanic Acid / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D010397:Penicillanic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D013407:Sulbactam / Q000494:pharmacology; D000078142:Tazobactam; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases
chemical_list: C112031:6-chloro-2-chloromethyl-2-methylpenam-3-carboxylic acid 1,1-dioxide; D004791:Enzyme Inhibitors; D065093:beta-Lactamase Inhibitors; D019818:Clavulanic Acid; C018008:brobactam; D010397:Penicillanic Acid; C062760:beta-lactamase SHV-2; D001618:beta-Lactamases; C034413:beta-lactamase TEM-1; D013407:Sulbactam; D000078142:Tazobactam